Pharma & Healthcare
Global Pneumococcal 13-valent Conjugate Vaccine Market Research Report 2024
- Nov 05, 24
- ID: 655243
- Pages: 74
- Figures: 77
- Views: 1
The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.
The global Pneumococcal 13-valent Conjugate Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pneumococcal 13-valent Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pneumococcal 13-valent Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pneumococcal 13-valent Conjugate Vaccine include Pfizer, Walvax, BIOKANGTAI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal 13-valent Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal 13-valent Conjugate Vaccine.
The Pneumococcal 13-valent Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pneumococcal 13-valent Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal 13-valent Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Walvax
BIOKANGTAI
Segment by Type
0.5ml
Other
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal 13-valent Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal 13-valent Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pneumococcal 13-valent Conjugate Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pneumococcal 13-valent Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pneumococcal 13-valent Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pneumococcal 13-valent Conjugate Vaccine include Pfizer, Walvax, BIOKANGTAI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal 13-valent Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal 13-valent Conjugate Vaccine.
The Pneumococcal 13-valent Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pneumococcal 13-valent Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal 13-valent Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Walvax
BIOKANGTAI
Segment by Type
0.5ml
Other
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal 13-valent Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal 13-valent Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pneumococcal 13-valent Conjugate Vaccine Market Overview
1.1 Product Definition
1.2 Pneumococcal 13-valent Conjugate Vaccine by Type
1.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 0.5ml
1.2.3 Other
1.3 Pneumococcal 13-valent Conjugate Vaccine by Application
1.3.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Pneumococcal 13-valent Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue 2019-2030
1.4.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales 2019-2030
1.4.3 Global Pneumococcal 13-valent Conjugate Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pneumococcal 13-valent Conjugate Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pneumococcal 13-valent Conjugate Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pneumococcal 13-valent Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Date of Enter into This Industry
2.8 Global Pneumococcal 13-valent Conjugate Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal 13-valent Conjugate Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal 13-valent Conjugate Vaccine Market Scenario by Region
3.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2019-2030
3.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2019-2024
3.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2025-2030
3.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2025-2030
3.4 North America Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.4.3 North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2019-2030)
4.1.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2019-2024)
4.1.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2025-2030)
4.1.3 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pneumococcal 13-valent Conjugate Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2019-2030)
5.1.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2019-2024)
5.1.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2025-2030)
5.1.3 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pneumococcal 13-valent Conjugate Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Pneumococcal 13-valent Conjugate Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Walvax
6.2.1 Walvax Company Information
6.2.2 Walvax Description and Business Overview
6.2.3 Walvax Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Walvax Pneumococcal 13-valent Conjugate Vaccine Product Portfolio
6.2.5 Walvax Recent Developments/Updates
6.3 BIOKANGTAI
6.3.1 BIOKANGTAI Company Information
6.3.2 BIOKANGTAI Description and Business Overview
6.3.3 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product Portfolio
6.3.5 BIOKANGTAI Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal 13-valent Conjugate Vaccine Industry Chain Analysis
7.2 Pneumococcal 13-valent Conjugate Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal 13-valent Conjugate Vaccine Production Mode & Process
7.4 Pneumococcal 13-valent Conjugate Vaccine Sales and Marketing
7.4.1 Pneumococcal 13-valent Conjugate Vaccine Sales Channels
7.4.2 Pneumococcal 13-valent Conjugate Vaccine Distributors
7.5 Pneumococcal 13-valent Conjugate Vaccine Customers
8 Pneumococcal 13-valent Conjugate Vaccine Market Dynamics
8.1 Pneumococcal 13-valent Conjugate Vaccine Industry Trends
8.2 Pneumococcal 13-valent Conjugate Vaccine Market Drivers
8.3 Pneumococcal 13-valent Conjugate Vaccine Market Challenges
8.4 Pneumococcal 13-valent Conjugate Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pneumococcal 13-valent Conjugate Vaccine by Type
1.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 0.5ml
1.2.3 Other
1.3 Pneumococcal 13-valent Conjugate Vaccine by Application
1.3.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Pneumococcal 13-valent Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue 2019-2030
1.4.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales 2019-2030
1.4.3 Global Pneumococcal 13-valent Conjugate Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pneumococcal 13-valent Conjugate Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pneumococcal 13-valent Conjugate Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pneumococcal 13-valent Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Date of Enter into This Industry
2.8 Global Pneumococcal 13-valent Conjugate Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal 13-valent Conjugate Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal 13-valent Conjugate Vaccine Market Scenario by Region
3.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2019-2030
3.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2019-2024
3.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2025-2030
3.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2025-2030
3.4 North America Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.4.3 North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2019-2030)
4.1.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2019-2024)
4.1.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2025-2030)
4.1.3 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pneumococcal 13-valent Conjugate Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2019-2030)
5.1.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2019-2024)
5.1.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2025-2030)
5.1.3 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pneumococcal 13-valent Conjugate Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Pneumococcal 13-valent Conjugate Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Walvax
6.2.1 Walvax Company Information
6.2.2 Walvax Description and Business Overview
6.2.3 Walvax Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Walvax Pneumococcal 13-valent Conjugate Vaccine Product Portfolio
6.2.5 Walvax Recent Developments/Updates
6.3 BIOKANGTAI
6.3.1 BIOKANGTAI Company Information
6.3.2 BIOKANGTAI Description and Business Overview
6.3.3 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product Portfolio
6.3.5 BIOKANGTAI Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal 13-valent Conjugate Vaccine Industry Chain Analysis
7.2 Pneumococcal 13-valent Conjugate Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal 13-valent Conjugate Vaccine Production Mode & Process
7.4 Pneumococcal 13-valent Conjugate Vaccine Sales and Marketing
7.4.1 Pneumococcal 13-valent Conjugate Vaccine Sales Channels
7.4.2 Pneumococcal 13-valent Conjugate Vaccine Distributors
7.5 Pneumococcal 13-valent Conjugate Vaccine Customers
8 Pneumococcal 13-valent Conjugate Vaccine Market Dynamics
8.1 Pneumococcal 13-valent Conjugate Vaccine Industry Trends
8.2 Pneumococcal 13-valent Conjugate Vaccine Market Drivers
8.3 Pneumococcal 13-valent Conjugate Vaccine Market Challenges
8.4 Pneumococcal 13-valent Conjugate Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Pneumococcal 13-valent Conjugate Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pneumococcal 13-valent Conjugate Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pneumococcal 13-valent Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal 13-valent Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal 13-valent Conjugate Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Pneumococcal 13-valent Conjugate Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Walvax Company Information
Table 76. Walvax Description and Business Overview
Table 77. Walvax Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Walvax Pneumococcal 13-valent Conjugate Vaccine Product
Table 79. Walvax Recent Developments/Updates
Table 80. BIOKANGTAI Company Information
Table 81. BIOKANGTAI Description and Business Overview
Table 82. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product
Table 84. BIOKANGTAI Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Pneumococcal 13-valent Conjugate Vaccine Distributors List
Table 88. Pneumococcal 13-valent Conjugate Vaccine Customers List
Table 89. Pneumococcal 13-valent Conjugate Vaccine Market Trends
Table 90. Pneumococcal 13-valent Conjugate Vaccine Market Drivers
Table 91. Pneumococcal 13-valent Conjugate Vaccine Market Challenges
Table 92. Pneumococcal 13-valent Conjugate Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal 13-valent Conjugate Vaccine
Figure 2. Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Type: 2023 & 2030
Figure 4. 0.5ml Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Pneumococcal 13-valent Conjugate Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pneumococcal 13-valent Conjugate Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pneumococcal 13-valent Conjugate Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Pneumococcal 13-valent Conjugate Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Pneumococcal 13-valent Conjugate Vaccine Report Years Considered
Figure 15. Pneumococcal 13-valent Conjugate Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Share by Manufacturers in 2023
Figure 17. Global 5 and 10 Largest Pneumococcal 13-valent Conjugate Vaccine Players: Market Share by Revenue in Pneumococcal 13-valent Conjugate Vaccine in 2023
Figure 18. Pneumococcal 13-valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 41. Mexico Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Brazil Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Argentina Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Colombia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Pneumococcal 13-valent Conjugate Vaccine by Type (2019-2030)
Figure 51. Global Revenue Market Share of Pneumococcal 13-valent Conjugate Vaccine by Type (2019-2030)
Figure 52. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 53. Global Sales Market Share of Pneumococcal 13-valent Conjugate Vaccine by Application (2019-2030)
Figure 54. Global Revenue Market Share of Pneumococcal 13-valent Conjugate Vaccine by Application (2019-2030)
Figure 55. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 56. Pneumococcal 13-valent Conjugate Vaccine Value Chain
Figure 57. Pneumococcal 13-valent Conjugate Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Pneumococcal 13-valent Conjugate Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pneumococcal 13-valent Conjugate Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pneumococcal 13-valent Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal 13-valent Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal 13-valent Conjugate Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Pneumococcal 13-valent Conjugate Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Walvax Company Information
Table 76. Walvax Description and Business Overview
Table 77. Walvax Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Walvax Pneumococcal 13-valent Conjugate Vaccine Product
Table 79. Walvax Recent Developments/Updates
Table 80. BIOKANGTAI Company Information
Table 81. BIOKANGTAI Description and Business Overview
Table 82. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product
Table 84. BIOKANGTAI Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Pneumococcal 13-valent Conjugate Vaccine Distributors List
Table 88. Pneumococcal 13-valent Conjugate Vaccine Customers List
Table 89. Pneumococcal 13-valent Conjugate Vaccine Market Trends
Table 90. Pneumococcal 13-valent Conjugate Vaccine Market Drivers
Table 91. Pneumococcal 13-valent Conjugate Vaccine Market Challenges
Table 92. Pneumococcal 13-valent Conjugate Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal 13-valent Conjugate Vaccine
Figure 2. Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Type: 2023 & 2030
Figure 4. 0.5ml Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Pneumococcal 13-valent Conjugate Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pneumococcal 13-valent Conjugate Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pneumococcal 13-valent Conjugate Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Pneumococcal 13-valent Conjugate Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Pneumococcal 13-valent Conjugate Vaccine Report Years Considered
Figure 15. Pneumococcal 13-valent Conjugate Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Share by Manufacturers in 2023
Figure 17. Global 5 and 10 Largest Pneumococcal 13-valent Conjugate Vaccine Players: Market Share by Revenue in Pneumococcal 13-valent Conjugate Vaccine in 2023
Figure 18. Pneumococcal 13-valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 41. Mexico Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Brazil Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Argentina Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Colombia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Pneumococcal 13-valent Conjugate Vaccine by Type (2019-2030)
Figure 51. Global Revenue Market Share of Pneumococcal 13-valent Conjugate Vaccine by Type (2019-2030)
Figure 52. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 53. Global Sales Market Share of Pneumococcal 13-valent Conjugate Vaccine by Application (2019-2030)
Figure 54. Global Revenue Market Share of Pneumococcal 13-valent Conjugate Vaccine by Application (2019-2030)
Figure 55. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 56. Pneumococcal 13-valent Conjugate Vaccine Value Chain
Figure 57. Pneumococcal 13-valent Conjugate Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232